President’s Message

Toshiaki NagasatoToshiaki Nagasato
We will contribute to global access to pharmaceuticals through new challenges and co-creation
Hirotada Takahashi President and Representative Director
KM Biologics Co., Ltd.

As a prevention and treatment professional under the Meiji Group, which aims to contribute to health in various life stages, KM Biologics’ mission is to create unique value and contribute to a healthy, abundant future for the people of the world.

The environment surrounding medicine and healthcare is changing rapidly, with new technologies being created every day. Leveraging the research, development, and manufacturing technologies that we have cultivated to date, KM Biologics will seek out opportunities for new challenges and accelerate the co-creation of innovative pharmaceuticals based on scientific evidence. Also, with the aim of improving pharmaceutical access in Asia and the rest of the world, based on co-creation and integrated management with Meiji Seika Pharma, which has a long history and strengths in overseas business, we will deliver the pharmaceuticals that are needed by people around the globe.

By fostering a corporate culture that will encourage employees to embrace challenges with pride and a sense of mission, KM Biologics will aim to realize sustainable growth and contribute to society together with all our stakeholders.